From Theory to Reality: Automating Process Development
Webinar Date/Time: Fri, Oct 25, 2024 11:00 AM EDT
Developing biomanufacturing processes that rely on automated technologies has grown from theory to reality. In this episode we explore automated technologies in use today and how they are streamlining process development, with an eye toward saving cost, time, and manufacturing footprint.
Register Free: https://www.pharmtech.com/pt_w/theory-to-reality
Event Overview:
In this episode of Drug Digest, industry experts discuss the ongoing advancement of automation in the biopharmaceutical industry. Developing biomanufacturing processes that rely on automated technologies has grown from theory to reality. In this episode we explore automated technologies in use today and how they are streamlining process development, with an eye toward saving cost, time, and manufacturing footprint.
Key Learning Objectives:
- Facilitating process development
- Pros/cons of switching to fully automated processes
- New skills? What should manufacturing personnel know under an automated biomanufacturing system?
Who Should Attend:
- Process development engineers
- CDMOs/CMOs
- Quality Control/Quality Assurance
- Data analysts
Register Free: https://www.pharmtech.com/pt_w/theory-to-reality
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
